Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vir Biotechnology Inc (NQ: VIR ) 7.930 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Vir Biotechnology Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > Drug makers, Scientists Working For Long COVID Treatments: Reuters March 25, 2022 Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID, Via Benzinga Up On Bad News March 22, 2022 Despite the plane crash in China, Boeing's stock is up today. Via Talk Markets World Markets News For Friday March 18, 2022 Buoyant global markets are closing the week and one good performer, Vir Biotech, today gained an impressive 6.09%. Via Talk Markets GSK/Vir Biotech's COVID-19 Antibody Associated With Resistance Mutations, New Research Shows March 11, 2022 According to new research in Australia, some people have developed sotrovimab-resistant mutations following infusions with the GlaxoSmithKline Plc (NYSE: GSK... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday February 23, 2022 On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 08, 2022 Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a... Via Benzinga Stocks That Hit 52-Week Lows On Monday March 07, 2022 On Monday, 524 stocks hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Taiwan... Via Benzinga Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach February 28, 2022 Photo credit: Marcelo Leal and Kate Hliznitsova on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended... Via Benzinga AstraZeneca, GSK's COVID-19 Therapies Lose Efficacy Against Omicron's Subvariants February 25, 2022 The FDA authorized an increased dose in the case of AstraZeneca Plc's (NASDAQ: AZN) pre-exposure prophylaxis drug Evusheld (tixagevimab and cilgavimab).... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022 March 03, 2022 Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,... Via Benzinga Recap: Vir Biotechnology Q4 Earnings February 24, 2022 Vir Biotechnology (NASDAQ:VIR) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... Via Benzinga The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company February 24, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (... Via Benzinga Stocks That Hit 52-Week Lows On Monday February 28, 2022 On Monday morning, 66 companies achieved new lows for the year. Noteable 52-Week Lows: Gilead Sciences (NASDAQ:GILD) was the largest firm on a market cap basis to set a... Via Benzinga World Markets News For Thursday February 17, 2022 Ericsson stock lost another 5.27% today in US markets. Via Talk Markets The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow February 20, 2022 Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... Via Benzinga Give peace a chance February 15, 2022 Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today. Via Talk Markets Preprint Suggests, Vir-GSK's COVID-19 Antibody Can Evade Omicron Sub-Variant February 10, 2022 In January, amid the omicron surge, WHO's expert panel recommended GlaxoSmithKline Plc (NYSE Via Benzinga Inflation inflating February 10, 2022 The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays. Via Talk Markets Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus February 08, 2022 Immunome Inc (NASDAQ: IMNM) shares rose before falling after reporting results from testing its experimental three-antibody cocktail Via Benzinga The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar February 08, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Panic reversal January 26, 2022 Crude oil inventories turned out to be fuller than expected, helping reduce the oil price rise. Via Talk Markets WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge January 14, 2022 An expert panel at the World Health Organization (WHO) recommended the use of treatments developed by Eli Lilly And Co (NYSE: LLY) and GlaxoSmithKline Plc... Via Benzinga GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19 January 13, 2022 GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have applied to the FDA to include intramuscular (IM) administration to sotrovimab... Via Benzinga Vir Biotechnology Expands Partnership With Bill & Melinda Gates Foundation, Launches New Antibody Research Initiative Aimed At A Functional Cure For HIV And Prevention Of Malaria; Foundation Has Committed $40M Equity Investment And $10M Grant January 13, 2022 Vir Biotechnology, Inc. (NASDAQ: VIR) today announced an expansion of its partnership with the Bill & Melinda Gates Foundation to include the advancement of innovative... Via Benzinga Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies January 13, 2022 Adagio Therapeutics Inc (NASDAQ: ADGI) shares gain during the premarket session after recent findings showing that ADG20 has neutralization activity against the omicron... Via Benzinga 20 Stocks Moving in Thursday's Pre-Market Session January 13, 2022 Gainers BTCS Inc. (NASDAQ: BTCS) rose 41% to $9.45 in pre-market trading after jumping 19% on Wednesday. Adagio Therapeutics, Inc. (NASDAQ: ADGI) rose 22.8% to $7.16 in pre-... Via Benzinga 50 Biggest Movers From Yesterday January 13, 2022 Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for... Via Benzinga US To Purchase 600K Additional Doses of GSK-Vir's COVID-19 Antibody Therapy January 11, 2022 The U.S. has agreed to buy 600,000 more doses of GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR) COVID-19 antibody... Via Benzinga Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant December 29, 2021 Pfizer (NYSE: PFE) is arguably one of the biggest leaders in COVID-19 technology, whether it’s their vaccine or their newly approved oral antiviral called Paxlovid. The... Via Benzinga The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus December 26, 2021 Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key... Via Talk Markets < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.